The Progressive Decline in Diabetic Skin Integrity Is Associated With Decreased Collagen Protein Content and Dysregulation of MicroRNA-29a

e j smith,m urencio,jianqiang xu,robert c caskey,m w morris,wengang wu,w dorsettmartin,lirong zhang,marc e mitchell,kenneth w liechty
DOI: https://doi.org/10.1016/j.jss.2011.11.290
IF: 2.417
2012-01-01
Journal of Surgical Research
Abstract:Introduction: We have shown that the biomechanical properties of murine and human diabetic skin are significantly inferior to non-diabetic skin at baseline. the major structural component of the skin responsible for skin integrity is type I collagen. MicroRNAs (miRNAs) are regulatory molecules that inhibit the translation of mRNAs at the post-transcriptional level, and have been shown to play an important role in the regulation of collagen content. Specifically, MiRNA-29a has been shown to inhibit the translation of Col1a2 mRNA. We hypothesized that the impaired biomechanical properties of murine diabetic skin at baseline is associated with decreased collagen protein and is due, in part, to increased miRNA-29a production. Methods: to test this hypothesis, we obtained samples from 4 and 20 week old diabetic and non-diabetic murine skin. the skin was processed for isolation of total protein and total cellular RNA. Western blot analysis was performed for type I collagen and real-time PCR performed for Col1a2 and miRNA-29a. Results: at 4 weeks of age diabetic and non-diabetic skin had similar type I collagen protein content, however, by 20 weeks the diabetic skin had significantly decreased type I collagen compared to non-diabetic (p<0.05) or 4 week old skin (p<0.05). at 4 weeks diabetic skin had significantly increased col1a2 and miRNA-29a expression compared to non-diabetic skin, and a col1a2/miRNA-29a ratio of 7.6:1 in diabetics. at 20 weeks the diabetic skin also had increased col1a2 and miRNA-29a expression compared to non-diabetic skin, but the col1a2/miRNA-29a ratio was significantly decreased to 2.7:1 in diabetics. Conclusions: These findings provide the first evidence that the impaired biomechanical properties of diabetic skin may be due, in part, to increased miRNA-29a expression relative to collagen gene expression, resulting in decreased collagen protein production. These results represent a novel potential therapeutic target to improve collagen content and subsequent biomechanical properties of diabetic skin to prevent injury, as well as to improve healing following injury.
What problem does this paper attempt to address?